Mirum Pharmaceuticals (MIRM) Prepaid Assets (2018 - 2026)
Mirum Pharmaceuticals (MIRM) recorded quarterly Prepaid Assets of $24.5 million in Q1 2026, up 35.31% quarter-over-quarter from $18.1 million in Q4 2025, and up 65.03% on a YoY basis from $14.9 million in Q1 2025.
Mirum Pharmaceuticals (MIRM) Prepaid Assets (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Prepaid Assets history runs 9 years deep, the most recent figure standing at $24.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 65.03% year-over-year to $24.5 million; the TTM figure through Mar 2026 stood at $24.5 million (up 65.03% YoY), while the FY2025 annual figure was $18.1 million, up 53.94% from the prior year.
- Prepaid Assets was $24.5 million for Q1 2026 at Mirum Pharmaceuticals, up from $18.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $24.5 million in Q1 2026 to a low of $3.8 million in Q2 2022.
- Historically, Prepaid Assets has averaged $12.4 million across 5 years, with a median of $10.9 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets dropped 16.32% in 2022, then soared 157.52% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $8.9 million in 2022, then rose by 22.22% to $10.9 million in 2023, then climbed by 7.76% to $11.8 million in 2024, then soared by 53.94% to $18.1 million in 2025, then jumped by 35.31% to $24.5 million in 2026.
- The last three Prepaid Assets figures came in at $24.5 million (Q1 2026), $18.1 million (Q4 2025), and $23.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mirum Pharmaceuticals | 6.29 Bn | 5.90 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.55 Mn |
| Dec 31, 2025 | 18.14 Mn |
| Sep 30, 2025 | 23.87 Mn |
| Jun 30, 2025 | 19.07 Mn |
| Mar 31, 2025 | 14.87 Mn |
| Dec 31, 2024 | 11.78 Mn |
| Sep 30, 2024 | 12.06 Mn |
| Jun 30, 2024 | 8.59 Mn |
| Mar 31, 2024 | 10.02 Mn |
| Dec 31, 2023 | 10.94 Mn |
| Sep 30, 2023 | 12.47 Mn |
| Jun 30, 2023 | 9.73 Mn |
| Mar 31, 2023 | 8.99 Mn |
| Dec 31, 2022 | 8.95 Mn |
| Sep 30, 2022 | 6.93 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.91 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 6.37 Mn |
| Jun 30, 2021 | 4.52 Mn |